drugset
drugset / Trial / NCT04703374

A Study to Compare PK, PD and Safety of CKD-382 in Healthy Subjects

NCT04703374 ↗

Phase 1 Unknown 48 enrolled Chong Kun Dang Pharmaceutical
RandomizedCrossoverOpen-labelTreatment

Summary

To compare pharmacokinetics, pharmacodynamics and safety after single/multiple administration of CKD-382 and D026 in healthy subjects

Timeline

Start
2020-09-25
Primary completion
2021-09
Completion
2021-09

Drugs

EvaluationDrugModalityDoseRoute
Subject CKD-382 Unknown — —
Subject D026 Unknown — —

Indications

gastroesophageal reflux disease